Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent calcium channels (VDCCs) in platyhelminths are essential membrane proteins that mediate the influx of calcium ions in response to membrane depolarization, playing a pivotal role in neuromuscular function and tegumental stability (Greenberg, 2005). These channels are composed of a pore-forming alpha-1 subunit and auxiliary subunits, including a parasite-specific beta subunit that is structurally distinct from those found in vertebrate hosts (Kohn et al., 2001). This divergence is characterized by the absence of certain conserved motifs and the presence of unique sequences that alter the channel's biophysical properties and pharmacological sensitivity (Park et al., 2002). The VDCC complex is the primary molecular target of praziquantel, the leading treatment for schistosomiasis and other trematode infections. Praziquantel acts as an allosteric modulator that triggers a rapid and sustained calcium influx, resulting in the spastic paralysis of the worm and the disruption of its protective outer layer (tegument) (Park et al., 2021). This mechanism effectively allows the host's immune system to recognize and eliminate the parasite, though the specific requirement of the beta subunit for drug efficacy remains a key area of anthelmintic research.
Praziquantel acts as an allosteric activator of the voltage-gated calcium channel complex, requiring the parasite-specific beta subunit for its unique pharmacological profile, leading to massive calcium influx and parasite paralysis (Park et al., 2021).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel subunit beta (VDCC-beta) (VDCC-beta).